Chun Chou
Overview
Explore the profile of Chun Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
946
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamdan A, Chou C, Rust D, Strand A
Cureus
. 2024 Sep;
16(8):e66338.
PMID: 39246900
A 24-year-old Ecuadorian female, previously diagnosed with acute fatty liver (AFL) during pregnancy, developed constitutional symptoms, jaundice, and abdominal pain in a subsequent pregnancy, prompting investigations that suggested a recurrence...
2.
Chou C, Martin G, Perera G, Awata J, Larson A, Blanton R, et al.
Front Cardiovasc Med
. 2024 Sep;
11:1455263.
PMID: 39221424
[This corrects the article DOI: 10.3389/fcvm.2023.1223244.].
3.
Do M, Shi W, Ji L, Ladewig E, Zhang X, Srivastava R, et al.
Immunity
. 2023 Nov;
56(11):2555-2569.e5.
PMID: 37967531
Tumors develop by invoking a supportive environment characterized by aberrant angiogenesis and infiltration of tumor-associated macrophages (TAMs). In a transgenic model of breast cancer, we found that TAMs localized to...
4.
Chou C, Vemon H, Jefferies J, Chin M
Front Cardiovasc Med
. 2023 Sep;
10:1282852.
PMID: 37745121
No abstract available.
5.
Chou C, Martin G, Perera G, Awata J, Larson A, Blanton R, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1223244.
PMID: 37435054
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder affecting 1 in 500 people in the general population. Characterized by asymmetric left ventricular hypertrophy, cardiomyocyte disarray and cardiac fibrosis,...
6.
Zhang X, Li S, Malik I, Do M, Ji L, Chou C, et al.
Nature
. 2023 Jun;
619(7970):616-623.
PMID: 37380769
In metazoan organisms, cell competition acts as a quality control mechanism to eliminate unfit cells in favour of their more robust neighbours. This mechanism has the potential to be maladapted,...
7.
Nixon B, Chou C, Li M
STAR Protoc
. 2023 Mar;
4(1):102136.
PMID: 36861825
Group 1 innate lymphocytes are heterogeneous, and their ontogeny and function remain ambiguous. Here, we describe a protocol to measure cell ontogeny and effector functions of natural killer (NK) and...
8.
Chou C, Chin M
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768840
The intention of this Special Issue is to highlight novel approaches and new paradigms for understanding the pathogenesis of hypertrophic cardiomyopathy (HCM) [...].
9.
Xia Y, Sandor K, Pai J, Daniel B, Raju S, Wu R, et al.
Immunity
. 2022 May;
55(7):1200-1215.e6.
PMID: 35637103
Soon after activation, CD4 T cells are segregated into BCL6 follicular helper (Tfh) and BCL6 effector (Teff) T cells. Here, we explored how these subsets are maintained during chronic antigen...
10.
Chou C, Zhang X, Krishna C, Nixon B, Dadi S, Capistrano K, et al.
Nature
. 2022 Apr;
605(7908):139-145.
PMID: 35444279
Cellular transformation induces phenotypically diverse populations of tumour-infiltrating T cells, and immune checkpoint blockade therapies preferentially target T cells that recognize cancer cell neoantigens. Yet, how other classes of tumour-infiltrating...